Direct-To-Consumer Genetic Testing Market Size, Share, Trends, And Forecast, 2026-2033 Market To Reach USD 6.80 Billion At 14.0% CAGR As Digital Health Adoption Accelerates

(MENAFN- GlobeNewsWire - Nasdaq) Digital health and telemedicine integration unlock remote interpretation, personalized consultations, and continuous monitoring, while preventive care drives at-home testing adoption.

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Direct-to-Consumer Genetic Testing Market Size, Share & Trends Analysis Report by Test Type, Technology, Distribution Channel, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global direct-to-consumer genetic testing market was valued at an estimated USD 2.32 billion in 2025 and is projected to reach USD 6.80 billion by 2033. The market is expected to expand at a compound annual growth rate of 14.0% from 2026 to 2033, supported by rising chronic disease prevalence, increasing demand for preventive and personalized healthcare, and continued advances in genetic diagnostics and testing technologies.

Integration with digital health platforms and telemedicine services is creating additional opportunities across the direct-to-consumer genetic testing market. These connected services support remote interpretation of test results, personalized consultations, and continuous health monitoring. As healthcare delivery becomes more digitally connected, consumers are gaining greater access to genetic information and professional guidance without relying exclusively on conventional clinical settings.

Chronic diseases remain a significant market driver as healthcare providers and consumers prioritize early risk assessment and preventive care. According to the World Health Organization, non-communicable diseases account for more than 74% of deaths worldwide. This substantial disease burden is increasing demand for accessible at-home genetic testing solutions that can identify inherited risk factors before symptoms emerge.

Direct-to-consumer genetic testing can provide insights into susceptibility to BRCA-related breast cancer, cardiovascular diseases, metabolic disorders, and other chronic conditions. Access to this information may support timely lifestyle changes, more informed medical discussions, and personalized monitoring strategies. As a result, genetic testing is becoming increasingly relevant to preventive healthcare and long-term health management.

The transition from a reactive, treatment-focused healthcare model toward proactive and individualized care is also strengthening market growth. Consumers are increasingly seeking information about genetic predisposition to cancer, cardiovascular conditions, celiac disease, and metabolic disorders. Greater awareness of personalized medicine, combined with improved testing accuracy and convenience, is expanding adoption among health-conscious consumers.

Regulatory progress is further supporting confidence in direct-to-consumer genetic testing. In 2025, Targeted Genomics received U.S. FDA 510(k) clearance for its direct-to-consumer GlutenID test. Using at-home saliva samples, the test analyzes key genetic markers associated with susceptibility to celiac disease. Its rapid, high-throughput testing capabilities and accessible results support broader genetic screening while improving the availability and reliability of consumer-focused risk assessment.

Market Segmentation

The report analyzes revenue growth at the global, regional, and country levels and evaluates industry trends across market sub-segments from 2021 to 2033. The analysis covers test type, technology, distribution channel, and region.

Test Type Outlook (Revenue, USD Million, 2021-2033)

• Nutrigenomics Testing
• Predictive Testing
• Carrier Testing
• Others

Technology Outlook (Revenue, USD Million, 2021-2033)

• Whole Genome Sequencing
• Single Nucleotide Polymorphism Chips
• Targeted Analysis
• Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

• Online Platform
• OTC

Regional Outlook (Revenue, USD Million, 2021-2033)

• North America: U.S., Canada, and Mexico
• Europe: UK, Germany, France, Spain, Italy, Denmark, Sweden, and Norway
• Asia-Pacific: Japan, China, India, Australia, Thailand, and South Korea
• Latin America: Brazil and Argentina
• Middle East & Africa: South Africa, Saudi Arabia, UAE, and Kuwait

Ongoing innovation in whole genome sequencing, single nucleotide polymorphism chips, and targeted analysis is expected to improve testing performance and broaden available applications. At the same time, online platforms and OTC distribution channels are making services more convenient for consumers. Together, technological development, digital healthcare integration, regulatory advancement, and growing interest in personalized disease prevention are expected to sustain expansion of the direct-to-consumer genetic testing market through 2033.

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2025 - 2033
Estimated Market Value (USD) in 2025	$2.32 Billion
Forecasted Market Value (USD) by 2033	$6.8 Billion
Compound Annual Growth Rate	14.0%
Regions Covered	Global

Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Technology
1.2.3. Distribution Channel
1.2.4. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.5.4.1. Data for Primary Interviews in North America
1.5.4.2. Data for Primary Interviews in Europe
1.5.4.3. Data for Primary Interviews in Asia Pacific
1.5.4.4. Data for Primary Interviews in Latin America
1.5.4.5. Data for Primary Interviews in MEA
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.9. Commodity Flow Analysis (Model 1)
1.9.1. Approach 1: Commodity Flow Approach
1.9.2. Volume Price Analysis (Model 2)
1.9.3. Approach 2: Volume Price Analysis
1.10. List of Secondary Sources
1.11. List of Primary Sources
1.12. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Test Type
2.2.2. Technology
2.2.3. Distribution Channel
2.2.4. Regional Outlook
2.3. Competitive Landscape Snapshot
Chapter 3. Direct-to-Consumer Genetic Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Prevalence of Chronic Diseases
3.2.1.2. Stronger Emphasis on Preventive and Personalized Healthcare
3.2.1.3. Continuous Advancements in Diagnostics and Testing
3.2.1.4. Integration of DTC Genetic Testing with Digital Health Platforms and Telemedicine
3.2.2. Market Restraint Analysis
3.2.2.1. Data Privacy and Security Concerns
3.2.2.2. Limited Clinical Validity and Risk of Misinterpretation
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter's Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Direct-to-Consumer Genetic Testing Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Global Direct-to-Consumer Genetic Testing Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
4.5. Nutrigenomics Testing
4.5.1. Nutrigenomics Testing Market Estimates and Forecasts, 2021 to 2033 (USD Million)
4.6. Predictive Testing
4.6.1. Predictive Testing Market Estimates and Forecasts, 2021 to 2033 (USD Million)
4.7. Carrier Testing
4.7.1. Carrier Testing Market Estimates and Forecasts, 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Others Market Estimates and Forecasts, 2021 to 2033 (USD Million)
Chapter 5. Direct-to-Consumer Genetic Testing Market: Technology Business Analysis
5.1. Technology Market Share, 2025 & 2033
5.2. Technology Segment Dashboard
5.3. Global Direct-to-Consumer Genetic Testing Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
5.5. Whole Genome Sequencing
5.5.1. Whole Genome Sequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)
5.6. Single Nucleotide Polymorphism Chips
5.6.1. Single Nucleotide Polymorphism Chips Market Estimates and Forecasts, 2021 to 2033 (USD Million)
5.7. Targeted Analysis
5.7.1. Targeted Analysis Market Estimates and Forecasts, 2021 to 2033 (USD Million)
5.8. Others
5.8.1. Others Market Estimates and Forecasts, 2021 to 2033
Chapter 6. Direct-to-Consumer Genetic Testing Market: Distribution Channel Estimates & Trend Analysis
6.1. Distribution Channel Market Share, 2025 & 2033
6.2. Segment Dashboard
6.3. Global Direct-to-Consumer Genetic Testing Market by Distribution Channel Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
6.5. Online Platform
6.5.1. Online Platform Market Estimates and Forecasts, 2021 to 2033 (USD Million)
6.6. OTC
6.6.1. OTC Market Estimates and Forecasts, 2021 to 2033 (USD Million)
Chapter 7. Direct-to-Consumer Genetic Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
7.3.1. Country analyses cover key country dynamics, target disease prevalence, regulatory framework, reimbursement framework, and market estimates and forecasts.
7.4. North America
7.4.1. North America Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. U.S. Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Canada Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Mexico Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
7.5.1. Europe Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. UK
7.5.2.1. UK Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Germany Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. France
7.5.4.1. France Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Italy Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Spain Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Denmark Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Sweden Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Norway Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Japan Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. China Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. India Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Australia Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. South Korea Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Thailand Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Brazil Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Argentina Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. South Africa Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Saudi Arabia Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. UAE Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Kuwait Direct-to-Consumer Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles and Listings
8.5.1. Company profiles cover overview, financial performance, product benchmarking, and strategic initiatives.
8.5.2. 23andMe
8.5.3. Family Tree DNA.
8.5.4. Ancestry.
8.5.5. Myriad Genetics, Inc.
8.5.6. Genesis HealthCare.
8.5.7. EasyDNA
8.5.8. Veritas
8.5.9. Full Genomes Corporation, Inc
8.5.10. Living DNA Ltd.
8.5.11. Color Health, Inc.
List of Tables [126]
List of Figures [80]
Companies Featured

• 23andMe
• Family Tree DNA
• Ancestry
• Genesis HealthCare
• EasyDNA,
• Veritas
• Myriad Genetics Inc.
• Full Genomes Corporation, Inc
• Living DNA Ltd.
• Color Health, Inc.

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN13102026004107003653ID1111799366